Protein biomarkers in renal transplantation
- PMID: 29106314
- DOI: 10.1080/14789450.2018.1396892
Protein biomarkers in renal transplantation
Abstract
The standard of care for monitoring renal transplant patients include transplant biopsy and serum creatinine measurements. These are invasive procedures and are late and nonspecific markers of injury. Proteomics and proteins can provide biomarkers for monitoring pathology and become a useful tool in detection and treatment of conditions that occur after transplant. Areas covered: A survey of 273 studies in the biomarker detection field which included proteomics relating to renal pathology and normal controls was done. Analysis of this data showed pathways and biomarkers specific to different pathologies such as: AR, CR, IRI, TI, VR, DGF, AABMR, ACMR, immunosuppressant toxicity, and infection. It also revealed biomarkers proposed for better detection of these pathologies and the strength (sensitivity and specificity) of such biomarkers. Finally, the field of proteomics in renal transplant in terms of its methodologies, current challenges in clinical translation, and possible solutions are also discussed. Expert commentary: An analysis of biomarkers of acute and chronic rejection revealed acute rejection may be a more inflammatory process. A comparison of proteomic and protein based (n = 183), transcriptomic (n = 1), and genomic (n = 4) studies revealed that proteomic and protein based approaches may offer a clearer picture of inflammation in acute rejection.
Keywords: Proteomics; bioinformatics; biomarkers of renal transplantation; omics; renal transplantation.
Similar articles
-
Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.Adv Clin Chem. 2018;85:91-113. doi: 10.1016/bs.acc.2018.02.005. Epub 2018 Mar 6. Adv Clin Chem. 2018. PMID: 29655463 Review.
-
A new method for classifying different phenotypes of kidney transplantation.Cell Biol Toxicol. 2016 Aug;32(4):323-32. doi: 10.1007/s10565-016-9337-x. Epub 2016 Jun 8. Cell Biol Toxicol. 2016. PMID: 27278387
-
Quantitative proteomic profiling of renal tissue in human chronic rejection biopsy samples after renal transplantation.Transplant Proc. 2015 Mar;47(2):323-31. doi: 10.1016/j.transproceed.2014.10.010. Transplant Proc. 2015. PMID: 25769567
-
Novel multivariate methods for integration of genomics and proteomics data: applications in a kidney transplant rejection study.OMICS. 2014 Nov;18(11):682-95. doi: 10.1089/omi.2014.0062. OMICS. 2014. PMID: 25387159 Free PMC article.
-
Renal transplant rejection markers.World J Urol. 2007 Oct;25(5):445-55. doi: 10.1007/s00345-007-0211-6. Epub 2007 Sep 5. World J Urol. 2007. PMID: 17786452 Review.
Cited by
-
Evaluation of NAG, NGAL, and KIM-1 as Prognostic Markers of the Initial Evolution of Kidney Transplantation.Diagnostics (Basel). 2023 May 25;13(11):1843. doi: 10.3390/diagnostics13111843. Diagnostics (Basel). 2023. PMID: 37296695 Free PMC article.
-
Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review.Int J Mol Sci. 2023 Mar 9;24(6):5287. doi: 10.3390/ijms24065287. Int J Mol Sci. 2023. PMID: 36982359 Free PMC article. Review.
-
Proteomics for Biomarker Discovery for Diagnosis and Prognosis of Kidney Transplantation Rejection.Proteomes. 2022 Jul 2;10(3):24. doi: 10.3390/proteomes10030024. Proteomes. 2022. PMID: 35893765 Free PMC article. Review.
-
The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?Front Immunol. 2021 Nov 22;12:667834. doi: 10.3389/fimmu.2021.667834. eCollection 2021. Front Immunol. 2021. PMID: 34880853 Free PMC article. Review.
-
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.Biomed Res Int. 2020 Oct 8;2020:2314128. doi: 10.1155/2020/2314128. eCollection 2020. Biomed Res Int. 2020. PMID: 33102575 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials